Sentences with phrase «new types of patients»

Case series designs to test schema therapy in new types of patients, or to replicate previous findings

Not exact matches

The case was yet more evidence that both the clinical trial doctors and the drug's developers would have to be more patient in assessing this new type of therapy.

The types of new information that Whitecoat will collect is based upon the Patient Reported Outcome Measures framework, which is gaining prominence.

Day care centers, night hospitals, walk - in clinics (where persons in crisis can go for help without appointments), halfway houses, and foster home programs for recovering mental patients who can not return to their families are examples of the types of new facilities that are beginning to appear in various parts of the country,

A nationally recognized speaker and New York Times Best Selling Author, Dr. Kartzinel has presented medical interventions that work to improve the lives of his patients who suffer from many types of medical conditions that include: autism, allergies, inflammatory bowel disease, chronic constipation, chronic diarrhea, sleep cycle disruptions, and hormonal imbalances.

Every year, people with very good intentions sit down and type out a list of New Year's resolutions, usually consisting of some lofty goals like «I will never touch fast food again» or «I will whip those saddle bags into shape» or «I will be a more patient parent.»

Every year, people with very good intentions sit down and type out a list of New Years resolutions, usually consisting of some lofty goals like «I will never touch fast food again» or «I will whip those saddle bags into shape» or «I will be a more patient parent.»

A new study shows that the drug fenofibrate might reduce the risk of cardiovascular events in patients with type 2 diabetes who have high levels of triglycerides and low levels of «good» cholesterol, despite being treated with statins.

In a paper published in the May 5 online issue of The Oncologist, researchers at the University of California, San Diego School of Medicine and Moores Cancer Center detail their experience evaluating 34 patients between December 2012 and June 2013 using a molecular tumor board — a new type of advisory group comprised of multidisciplinary experts, including those in the fields of tumor genetics, basic science and bioinformatics.

A one - time intravenous infusion of the high dose of gene therapy extended the survival of patients with spinal muscular atrophy type 1 (SMA1) in a Phase 1 clinical trial, according to a study published in the New England Journal of Medicine.

A new type of cancer drug developed at Johns Hopkins University in Baltimore, Maryland, but not yet tested in clinical trials may have triggered the deaths of three patients who were undergoing an alternative cancer treatment by a nonmedical practitioner in Germany.

A pilot study testing a new type of drug in patients with chronic diarrhea has shown promising effects on reducing their symptoms.

Prior to the new study, researchers had already developed a more basic type of skin substitute that had been used successfully in human patients, said Takashi Tsuji, a team leader at RIKEN Center forDevelopmental Biology in Japan.

The new findings build on prior research from the Dhodapkar lab demonstrating that patients with Gaucher disease, an inherited lipid storage disorder, have a significant increased risk for developing myeloma; and the discovery of a subset of lipid - reactive immune cells, called type II NKT - TFH, that promote the development of plasma cells.

By the early 1990s, Swedo and the NIMH team were treating the Sydenham group and pioneering some of the same types of treatments used for patients like Paul Michael today: steroids such as prednisone to stanch the tide of immune molecules; plasmapheresis, a technique to filter the blood, cleanse it of autoantibodies, and return it intact to the patient; and intravenous delivery of a new, healthy immune system with IVIG.

«Our findings suggest that this new drug combination would also help patients with this type of aggressive breast cancer as well as other cancers, such as lung, prostate and ovarian cancers,» Dr. Rassool says.

Last week, scientists at Harvard University and Columbia University announced that they had proved the viability of a new way to study a disease — amyotrophic lateral sclerosis — by reprogramming cells from a patient to become pluripotent stem cells, which can then become any type of cell or tissue.

The researchers hope these findings will aid in developing new treatments by using animal models that more closely represent the types of mutations apparent in the vast majority of patients with enchrondromas.

«This newer, coupled approach gives us hope that personalized cell therapies could be an important option for high - risk CLL patients on these types of drugs.»

«We can confidently say that this type of prosthesis is a viable choice and the new infection classification system, developed by the Osseointegrated Group of Australia, provides an effective tool for the use in patient selection as well as infection management.»

«This is a very exciting finding, obtained by studying patients» cells, that has the potential to result in a new treatment for this chronic complication of longstanding Type 1 diabetes,» Dr. Folli said.

I picked up my last chart of the morning and saw that it was another new patient with Type 2 diabetes.

The new RYBP biomarker could predict which patients will benefit from specific types of chemotherapy.

New research led by Li Ding, Ph.D., of Washington University School of Medicine in St. Louis, shows that current approaches to genome analysis systematically miss detecting a certain type of complex mutation in cancer patients» tumors.

Prof Andrés Cervantes, Biomedical Research Institute, INCLIVA, University of Valencia, Spain, ESMO spokesperson, not involved in the study, commented: «This is a new understanding of how to treat a select group of patients that are wild - type for the KRAS, NRAS, BRAF and PIK3CA genes who can be treated with the same anti-EGFR antibody and a change in chemotherapy following progression.

MIT engineers hope to improve treatment for diabetes patients with a new type of engineered insulin.

I detect gratitude from my patients — a new type of satisfaction.

This could be a good way to test new types of drugs that target cancer cells specifically and spare patients the side effects from treatments if they are not working.»

An essential new way to move discoveries forward has emerged in the form of multi-stakeholder collaborations involving three or more different types of organizations, such as drug companies, government regulators and patient groups, write Magdalini Papadaki, a research associate, and Gigi Hirsch, a physician - entrepreneur and executive director of the MIT Center for Biomedical Innovation.

On June 18, neurosurgeons at the University of Alabama at Birmingham implanted a new type of electrical stimulator to control seizures in patients with difficult - to - control epilepsy.

Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple - myeloma patients.

New findings from large - scale studies of more than 3.6 million people who underwent screening for cardiovascular disease reveals that a person's age and gender affects the prevalence of certain types of peripheral vascular diseases (PVD), and that diabetes is a major risk factor for developing these diseases, even in patients without heart disease.

A new study by researchers from the University of Chicago Medicine, based on a 6 - month clinical trial, finds that use of a CGM is cost - effective for adult patients with type 1 diabetes when compared to daily use of test strips.

A growing body of evidence suggests that rapid detection of, and aggressive new therapies for, type - 1 diabetes benefit patients in the long run, possibly halting the autoimmune attack on the pancreas and preserving some of the body's ability to make insulin.

Scientists at Cedars - Sinai have developed a new way to identify which prostate cancer patients are likely to develop aggressive types of the disease even if their tumors at first appear to be lower risk.

In addition, patients received new types of wound dressings designed to reduce the chance of infection.

In addition to new diabetics, people who are at risk of developing type - 1 diabetes, such patients» close relatives, also may benefit from the test because it will allow doctors to quickly and cheaply track their auto - antibody levels before they show symptoms.

«New tumor analysis method identifies high - risk prostate cancer: Cancer cells» genetic pathways show which patients are likely to develop aggressive types of the disease.»

New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.

The new study analyzed heart disease risk factors among more than 3,900 patients who were treated for ST - elevation myocardial infarction, or STEMI — the most severe and deadly type of heart attack — at Cleveland Clinic between 1995 and 2014.

«While there is understandable excitement around new therapies that enlist the immune system to fight cancer, we are still in a situation where greater than half of patients don't respond in melanoma and the response rate is even worse in other cancer types,» Hanks said.

But he points out that because patients experience multiple types of itch, the new findings don't diminish the importance of the STT in sending itch information to the brain.

«It could also be used to identify new types of amyloids and presymptomatic patients who are at risk of developing the disease,» says Hammarström and collaborator professor Peter Nilsson.

A lung cancer diagnosis appears to put patients at the greatest risk of suicide when compared to the most common types of non-skin cancers, according to new research presented at the ATS 2017 International Conference.

To help improve the care these patients receive, a team of pediatricians and computer scientists is developing a new type of social network that turns doctors and patients into research collaborators.

Patients with chest pain have similar rates of heart attacks and other major cardiac events within two years whether they were evaluated with a new type of CT scan or the traditional stress test, according to results presented today by Duke Medicine researchers at a meeting of the American College of Cardiology.

Surgeons are treating patients with a new type of hip implant that could lead to better outcomes for younger, more active people requiring surgery.

Two new papers published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]-RRB- reveal the importance of both the amount and timing of physical activity in reducing the risk of developing type 2 diabetes (T2D), as well as aiding the management of the disease in existing T2D patients.

«New pharmacologic options are welcomed by practicing clinicians like me who struggle to work with our patients who have diabetes — each of whom have unique circumstances that require customized approaches,» says Dr. Vivian Fonseca, M.D., Chief, Section of Endocrinology, Tulane University Medical Center, New Orleans, Louisiana, and author of a paper describing new pharmacological advances in the management of type 2 diabetNew pharmacologic options are welcomed by practicing clinicians like me who struggle to work with our patients who have diabetes — each of whom have unique circumstances that require customized approaches,» says Dr. Vivian Fonseca, M.D., Chief, Section of Endocrinology, Tulane University Medical Center, New Orleans, Louisiana, and author of a paper describing new pharmacological advances in the management of type 2 diabetNew Orleans, Louisiana, and author of a paper describing new pharmacological advances in the management of type 2 diabetnew pharmacological advances in the management of type 2 diabetes.

NEW YORK (November 18, 2014)-- The addition of mitral valve (MV) repair (a valve of the heart) to coronary artery bypass grafting (CABG), a type of open - heart surgery, did not result in significant benefit to the patient and was associated with increased risk of neurological events.